Baker Bros. Advisors LP, a director at Madrigal Pharmaceuticals, Inc., purchases $35M of stock
An open-market purchase between Nov 4 and Nov 6, reported to the SEC on Nov 6.
Insider buying at Madrigal Pharmaceuticals, Inc.: Baker Bros. Advisors LP, a director, added 91,806 shares between Nov 4 and Nov 6 for $35 million, at an average of $381.49 a share, a Form 4 filed on Nov 6 shows.
The purchase was made in the open market, not through an award, an option exercise or a plan. After the trade, the filing lists 2,040,682 shares held.
The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Madrigal Pharmaceuticals, Inc. (MDGL) |
|---|---|
| Insider | Baker Bros. Advisors LP |
| Role | Director |
| Transaction | Open-market purchase (code P) |
| Shares | 91,806 |
| Average price | $381.49 |
| Value | $35,023,032 |
| Trade dates | Nov 4 to Nov 6, 2026 |
| Filed with the SEC | Nov 6, 2026, 5:30 PM ET |
| Shares held after | 2,040,682 |
| Ownership | Indirect |
| Rule 10b5-1 plan | Not marked in the filing |
View this Form 4 in Insider Stock Trader
Browse the insider trading newsroom · Read more MDGL insider trading news
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
